Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.

age, stage, gender, histology, and smoking status, we observed a weakly significant correlation between gender and gal-9Δ5 (r = 0.24) and between age and respectively gal-1 (r = 0.26), gal-9 (r = −0.25) and gal-9Δ5 (r = −0.30).

also in 1,387 other papers

Galectin-3, which has also been associated with poor disease outcome in lung cancer patients [16] , [17] , did not reach statistical significance in our patient group.

also in 111,027 other papers